(Q44233587)

1 December 2017

title

Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain (English)

1 reference

1 December 2017

2

1 reference

1 December 2017

Eugen B Petcu

1

0 references

author name string

H Smith

series ordinal

3

1 reference

1 December 2017

publication date

1 September 2002

1 reference

Journal of Pain and Symptom Management

1 December 2017

published in

1 reference

1 December 2017

volume

24

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

281-284

1 reference

The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

Pamidronate in incident pain due to bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900478-5

7 January 2021

10.1016/S0885-3924(02)00478-5

Identifiers

DOI

1 reference

1 December 2017

1 reference